Immunocore, a mid-sized drugmaker known for its successful launch of the melanoma drug Kimmtrak, is now setting its sights on…
Trending
- Post Holdings elevates cereal, pet food exec to COO role
- Embrace dissent, and fade into the background
- Cerebral Turns Page with First-Ever Acquisition After Years of Turmoil
- Is laughter a form of therapeutic medicine?
- Omada grows revenue, membership in public earnings debut
- Childhood Vaccinations Are Down. Schools Are Bracing for Outbreaks
- War-zone hospital patients found to carry multidrug-resistant bacteria
- Easy Cherry Brownies Recipe